Search Results - "FREDRIX, Hanny"
-
1
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
Published in Bone marrow transplantation (Basingstoke) (01-12-2020)“…Acute myeloid leukemia (AML) is an immune-susceptible malignancy, as demonstrated by its responsiveness to allogeneic stem cell transplantation (alloSCT)…”
Get full text
Journal Article -
2
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy
Published in Oncoimmunology (03-10-2018)“…Adoptive T cell therapy has shown clinical potential for patients with cancer, though effective treatment is dependent on longevity and potency of the…”
Get full text
Journal Article -
3
A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR
Published in PloS one (28-06-2011)“…Nonmyeloablative allogeneic stem cell transplantation (SCT) can induce remission in patients with renal cell carcinoma (RCC), but this graft-versus-tumor (GVT)…”
Get full text
Journal Article -
4
A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia
Published in The Journal of experimental medicine (18-01-1999)“…Human minor histocompatibility antigens (mHags) play an important role in the induction of cytotoxic T lymphocyte (CTL) reactivity against leukemia after human…”
Get full text
Journal Article -
5
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
Published in Cancer Immunology, Immunotherapy (01-02-2013)“…Dendritic cell (DC)-based vaccination boosting antigen-specific immunity is being explored for the treatment of cancer and chronic viral infections. Although…”
Get full text
Journal Article -
6
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8+ T cells in NOD/SCID/IL2Rg(null) mice
Published in Cancer Immunology, Immunotherapy (01-05-2015)“…Allogeneic stem cell transplantation (allo-SCT) can be a curative therapy for patients suffering from hematological malignancies. The therapeutic efficacy is…”
Get full text
Journal Article -
7
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
Published in Cancer Immunology, Immunotherapy (01-08-2013)“…The introduction of autologous stem cell transplantation (SCT) and novel drugs has improved overall survival in multiple myeloma (MM) patients. However,…”
Get full text
Journal Article -
8
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses
Published in The Journal of immunology (1950) (01-10-2016)“…Potent immunotherapies are urgently needed to boost antitumor immunity and control disease in cancer patients. As dendritic cells (DCs) are the most powerful…”
Get full text
Journal Article -
9
B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation
Published in The Journal of immunology (1950) (01-07-2012)“…Allogeneic stem cell transplantation (allo-SCT) can cure hematological malignancies by inducing alloreactive T cell responses targeting minor…”
Get full text
Journal Article -
10
Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18
Published in Journal of immunotherapy (1997) (01-05-2015)“…Dendritic cell (DC)-based vaccination is an appealing strategy to boost graft-versus-tumor immunity after allogeneic stem cell transplantation (allo-SCT), and…”
Get full text
Journal Article -
11
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8 super(+) T cells in NOD/SCID/IL2Rg(null) mice
Published in Cancer Immunology, Immunotherapy (01-05-2015)“…Allogeneic stem cell transplantation (allo-SCT) can be a curative therapy for patients suffering from hematological malignancies. The therapeutic efficacy is…”
Get full text
Journal Article -
12
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8^sup +^ T cells in NOD/SCID/IL2Rg(null) mice
Published in Cancer immunology, immunotherapy (01-05-2015)“…Allogeneic stem cell transplantation (allo-SCT) can be a curative therapy for patients suffering from hematological malignancies. The therapeutic efficacy is…”
Get full text
Journal Article -
13
Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1–reactive cytotoxic T cells
Published in Blood (05-03-2009)“…CD8+ T cells recognizing minor histocompatibility antigens (MiHAs) on leukemic stem and progenitor cells play a pivotal role in effective graft-versus-leukemia…”
Get full text
Journal Article -
14
Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation
Published in Blood (18-11-2011)“…Abstract 4136 Allogeneic stem cell transplantation (allo-SCT) can induce remission in patients with hematological malignancies due to graft-versus-tumor (GVT)…”
Get full text
Journal Article -
15
Expression of P2X5 in lymphoid malignancies results in LRH‐1‐specific cytotoxic T‐cell‐mediated lysis
Published in British journal of haematology (01-06-2008)“…Summary Minor histocompatibility antigens (MiHA) selectively expressed by haematopoietic cells are attractive targets for specific immunotherapy after…”
Get full text
Journal Article -
16
Efficient Activation of LRH-1―specific CD8+ T-cell Responses From Transplanted Leukemia Patients by Stimulation With P2X5 mRNA-electroporated Dendritic Cells
Published in Journal of immunotherapy (1997) (01-07-2009)“…Alloreactive CD8+ T cells targeting minor histocompatibility antigens (MiHA) on malignant cells of the recipient play a pivotal role in graft-versus-tumor…”
Get full text
Journal Article -
17
Use of RNA Electroporated DC for Activation of LRH-1 Specific Cytotoxic T Lymphocytes in the Treatment of Lymphoid Malignancies
Published in Blood (16-11-2006)“…Allogeneic hematopoietic stem cell transplantation (HSCT) is a potent treatment for patients with hematological malignancies. The therapeutic efficacy is…”
Get full text
Journal Article -
18
Bi‐directional allelic recognition of the human minor histocompatibility antigen HB‐1 by cytotoxic T lymphocytes
Published in European journal of immunology (01-10-2002)“…Human minor histocompatibility antigens (mHag) are target antigens of the graft‐versus‐leukemia response observed after allogeneic HLA‐identical stem cell…”
Get full text
Journal Article -
19
Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens
Published in Journal of immunological methods (01-01-2008)“…Minor histocompatibility antigens (mHAgs) constitute the target antigens of the T cell-mediated graft-versus-leukemia response after HLA-identical allogeneic…”
Get full text
Journal Article -
20
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL
Published in The Journal of immunology (1950) (15-01-1997)“…CTL directed against minor histocompatibility Ags (mHag) play a major role in antileukemia reactivity after HLA-identical bone marrow transplantation. Some of…”
Get full text
Journal Article